David Schwartz
Pulmonary Disease · Aurora, CONPI 1790869675
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $470,933 of the $471,100 with a category attached, or 100.0%. Vertex accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $137,500 and has fallen 100.0% since, to $22 in 2023. Among pulmonary disease clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $8565.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$471K
- AstraZeneca$22
Across 5 payments — averaging $1,250,315 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$6.3M
What the payments were for
- Consulting fees$470,933100%
- Food & beverage$1670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 54 | $471,078 |
| AstraZeneca | 1 | $22 |
How this compares
$471,100 in reported general payments places this provider in the 95th percentile of 248 pulmonary disease providers in Colorado.
Other pulmonary disease in Aurora
- David BadeschAurora$134K
- Robert WinnAurora$70K
- Richard AlbertAurora$64K
- Joyce LeeAurora$63K
- Kevin DavidsonAurora$19K
- Melanie KoenigshoffAurora$15K
- Nina ThomasAurora$14K
- Raymond ParrishAurora$14K
- Brian GrahamAurora$14K
- Michael WechslerDenver$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.